Hepatocellular proliferation in response to a peroxisome proliferator doesnot require TNF alpha signaling

Citation
Sp. Anderson et al., Hepatocellular proliferation in response to a peroxisome proliferator doesnot require TNF alpha signaling, CARCINOGENE, 22(11), 2001, pp. 1843-1851
Citations number
77
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
CARCINOGENESIS
ISSN journal
01433334 → ACNP
Volume
22
Issue
11
Year of publication
2001
Pages
1843 - 1851
Database
ISI
SICI code
0143-3334(200111)22:11<1843:HPIRTA>2.0.ZU;2-L
Abstract
Rodents exposed to peroxisome proliferator xenobiotics respond with marked increases in hepatocellular replication and growth that results in tumor fo rmation. Recently, tumor necrosis factor-alpha (TNF alpha) was proposed as the central mediator of this maladaptive response. To define the role of TN F alpha signaling in hepatocellular growth induced by peroxisome proliferat ors we administered three daily gavage doses of the potent peroxisome proli ferator, Wy-14 643, to mice nullizygous for TNF-receptor I (TNFR1), TNFR2, or both receptors. We demonstrate here that regardless of genotype the mice responded with almost identical increases in liver to body weight ratios a nd hepatocyte proliferation. Lacking evidence that TNF alpha signaling medi ates these effects, we then examined the possible contribution of alternati ve cytokine pathways. Semi-quantitative, reverse transcriptase polymerase c hain reaction analysis revealed that wild type mice acutely exposed to Wy-1 4 643 had increased hepatic expression of Il1 beta, Il1r1, Hnf4, and Stat3 genes. Moreover, hepatic adenomas from mice chronically exposed to Wy-14 64 3 had increased expression of Il1 beta, Il1r1, Il6, and Ppary1. Expression of Il1 alpha, Tnf alpha, Tnfr1, Tnfr2, Ppar alpha, or C/ebp alpha was not a ltered by acute Wy-14 643 exposure or in adenomas induced by Wy-14643. Thes e data suggest that the hepatic mitogenesis and carcinogenesis associated w ith peroxisome proliferator exposure is not mediated via TNFa but instead m ay involve an alternative pathway requiring IL1 beta and IL6.